The global plasma protein therapeutics market size was valued at USD 32.25 Billion in 2025, driven by increasing demand for plasma protein therapies across the globe. The market size is anticipated to grow at a CAGR of 6.10% during the forecast period of 2026-2035 to achieve a value of USD 58.30 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
6.1%
Value in USD Billion
2026-2035
*this image is indicative*
Plasma-derived therapies play a crucial role in enhancing the quality of life for individuals by replacing missing or deficient proteins. These therapies are often a lifeline for patients who rely on them, necessitating regular infusions or injections throughout their lifetimes. The conditions treated by plasma protein therapies are typically categorized as rare diseases since they affect a relatively small percentage of the population, with many being genetic and chronic in nature.
The market is experiencing robust growth driven by the increase in demand for plasma protein therapies, particularly for conditions like hemophilia and Primary Immunodeficiency Disorders (PID), along with various other medical conditions. Novel drug therapies have gained high acceptance and accessibility, further fuelling the market expansion. Moreover, there is a significant increase in research and development efforts as well, particularly in the field of hemophilia therapy, contributing to the global plasma protein therapeutics market growth.
Additionally, the rising prevalence of autoimmune disorders has further amplified the demand for plasma protein therapeutics. Immunoglobulins are taking the lead in the product landscape, underscoring their importance in treating various medical conditions.
The EMR’s report titled “Plasma Protein Therapeutics Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Region
The market is experiencing substantial growth driven by factors such as continuous product innovations in the field of plasma protein therapeutics adding options to existing treatment options and improving patient outcomes. The market is also driven by the increasing prevalence of autoimmune disorders and genetic disorders worldwide resulting in increased demand for these therapies, further propelling the plasma protein therapeutics market demand. The rising geriatric population that often requires such treatments has contributed to the market growth as well.
Government initiatives aimed at improving healthcare accessibility and affordability also play a pivotal role in fuelling the market's upward trajectory. Moreover, there is an escalating demand for albumin and an increased use of plasma proteins in pharmaceuticals, underlining their critical role in various medical treatments. Furthermore, the rising usage of immunoglobulin therapies has added to the market's overall growth, making the market a vibrant and evolving sector within the healthcare sector.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 32.25 Billion in 2025, driven by the continuous product innovations in the field of plasma protein therapeutics.
The market is anticipated to grow at a CAGR of 6.10% during the forecast period of 2026-2035 to reach a market value of USD 58.30 Billion by 2035.
The increasing prevalence of autoimmune disorders and genetic disorders are among the major factors driving the market growth.
An increase in the number of research and development activities, particularly in the field of hemophilia therapy, is a major trend influencing the market growth.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Different products in the market include immunoglobulin, albumin, plasma-derived factor, among other products.
They find wide applications in hemophilia, idiopathic thrombocytopenic purpura, and primary immunodeficiencies, among other applications.
End users in the market are hospitals, home care, and ASCs.
Key players involved in the market are CSL Limited, Baxter International, Bio Products Laboratory Ltd, Octapharma AG, Kedrion, SpA, Becton, Dickinson and Company, Takeda Pharmaceutical, Grifols, S.A., ADMA Biologics Inc, and Bayer AG.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share